Product Categories
Country: | China |
---|---|
Tel: | 60753300-53010 |
Mobile: | 13671599112 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Cabazitaxel | C45H57NO14 | 183133-96-2 | Details |
NA | 917572-43-1 | Details |
lenvatinib Mesylate | C22H23ClN4O7S | 857890-39-2 | Details |
Lenvatinib Impurity | C13H14N2O3 | 2143930-77-0 | Details |
Apalutamide | C21H15F4N5O2S | 956104-40-8 | Details |
ABT-199 | C45H50ClN7O7S | 1257044-40-8 | Details |
Rucaparib | C29H34FN3O5S | 1327258-57-0 | Details |
Crisaborole | C14H10BNO3 | 906673-24-3 | Details |
Capecitabine | C15H22FN3O6 | 154361-50-9 | Details |
Oseltamivir phosphate | C16H31N2O8P | 204255-11-8 | Details |
Lapatinib impurity A;2-chloro-4-((6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-yl)amino)phenol | C22H21ClN4O4S | 1268997-70-1 | Details |
Lapatinib impurity B;N-De[2-(Methylsulfonyl)ethyl] Lapatinib | C26H20ClFN4O2 | 697299-82-4 | Details |
Lapatinib impurity D;N-De[2-(Methylsulfonyl)ethyl] Lapatinib | C29H26ClFN4O4S | 1393112-45-2 | Details |
Afatinib impurity;Afatinib Impurity des-EJA | C22H20ClFN4O3 | 2223677-64-1 | Details |
Afatinib impurity;Ethyl hydrogen (2-((4-((3-chloro-4-fluorophenyl)amino) -7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate | C24H25ClFN5O3 | 1680184-59-1 | Details |
Lapatinib impurity F;Lapatinib IMpurity 8 | C26H19ClFN3O3 | 320337-48-2 | Details |
Lapatinib impurity G;5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde | C26H17ClFN3O3 | 231278-84-5 | Details |
Lapatinib impurity I;Lapatinib impurity P | C29H27FN4O4S | 633370-23-7 | Details |
Lapatinib impurity J;3-Chloro-4-(3-fluorobenzyloxy)aniline | C13H11ClFNO | 202197-26-0 | Details |
Lapatinib impurity H;Lapatinib Impurity 4 | C55H43Cl2F2N7O6S | 2172855-57-9 | Details |
Roxadustat | C19H16N2O5 | 808118-40-3 | Details |
Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, hydrochloride, hydrate (1:1:2) | C28H25ClF3N7O2 | 923289-71-8 | Details |
Abiraterone | C24H31NO | 154229-19-3 | Details |
Abiraterone Impurity | C29H39NO2 | 1431753-70-6 | Details |
Abiraterone Impurity | C26H33NO2 | 165334-69-0 | Details |
4-Dimethylaminopyridine | C7H10N2 | 1122-58-3 | Details |
Sorafenib tosylate | C21H16ClF3N4O3.C7H8O3S | 475207-59-1 | Details |
(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate | Details |
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate | 1239-13-6 | Details |
Palbociclib impurity C | Details |
4-Amino-3-fluorophenol | C6H6FNO | 399-95-1 | Details |
4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE | C13H12FN3O2 | 757251-39-1 | Details |
4-[2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]-N-methylpyridine-2-carboxamide | C20H18FN5O3 | 1855006-12-0 | Details |
FLUCOFURON | C15H8Cl2F6N2O | 370-50-3 | Details |
Regorafenib Impurity | C35H23Cl2F7N6O5 | 2098799-13-2 | Details |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | C17H14N4O2 | 641569-94-0 | Details |
Benzamide, 3-[[5-chloro-4-(3-pyridinyl)-2-pyrimidinyl]amino]-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]- | C28H21ClF3N7O | 2469039-94-7 | Details |
Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
Nintedanib Ethanesulfonate Salt | C33H39N5O7S | 656247-18-6 | Details |
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate | C24H23F3N4O5 | 442526-91-2 | Details |
Neratinib | C30H29ClN6O3 | 698387-09-6 | Details |
Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
Afatinib diMaleate | C28H29ClFN5O7 | 850140-73-7 | Details |
1-(4-cyano-3-(trifluoroMethyl)phenyl)-3-(3-cyano-4-(trifluoroMethyl)phenyl)thiourea | C17H8F6N4S | 1415564-70-3 | Details |
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine | C12H15FN2O3 | 1289942-66-0 | Details |
relugolix impurity | C27H24F2N6O3S | 1589503-93-4 | Details |
Enzalutamide Impurity 9 | C10H7F3N2OS | 1895865-10-7 | Details |
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide | C14H20N4O3 | 1139453-98-7 | Details |
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate | C17H13NO4 | 2093243-16-2 | Details |
1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-hydroxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea | C28H25F2N7O5S | 1801551-07-4 | Details |
BIBF 1202 | C30H31N5O4 | 894783-71-2 | Details |
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide | C14H22N4O | 262368-30-9 | Details |
Oxo Enzalutamide | C21H16F4N4O3 | 1242137-18-3 | Details |
Enzalutamide carboxylic acid | C20H13F4N3O3S | 1242137-15-0 | Details |
1-Piperazinecarboxylic acid, 4-[6-[[7-cyclopentyl-6-[(diMethylaMino)carbonyl]-7H-pyrrolo[2,3-d]pyriMidin-2-yl]aMino]-3-pyridinyl]-, 1,1-diMethylethyl ester | C28H38N8O3 | 1374639-78-7 | Details |
4-[1-(4-cyano-3-trifluoromethyl-phenylcarbamoyl)-1-methyl-ethylamino]-2-fluoro-N- | C20H18F4N4O2 | 1289942-55-7 | Details |
4-Amino-2-(trifluoromethyl)benzonitrile | C8H5F3N2 | 654-70-6 | Details |
N,N''-Bis[3-(trifluoromethyl-4-cyanophenyl]urea | C17H8F6N4O | 1895865-11-8 | Details |
5'-Deoxy-5-fluorocytidine | C9H12FN3O4 | 66335-38-4 | Details |
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine | C13H16FN3O6 | 161599-46-8 | Details |
5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | C15H22FN3O6 | 910129-15-6 | Details |
Capecitabine-2',3'-cyclic Carbonate | C16H20FN3O7 | 921769-65-5 | Details |
Doxifluridine | C9H11FN2O5 | 3094-09-5 | Details |
5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine | C15H22FN3O6 | 162204-30-0 | Details |
Carfilzomib | C40H57N5O7 | 868540-17-4 | Details |
Ribociclib | C27H36N8O5 | 1374639-79-8 | Details |
Lapatinib ditosylate | C41H40ClFN4O11S3 | 388082-78-8 | Details |
Enzalutamide | C20H14F4N4O2S | 1242137-16-1 | Details |
Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
Afatinib | C24H25ClFN5O3 | 850140-72-6 | Details |
Irinotecan hydrochloride trihydrate | C33H45ClN4O9 | 136572-09-3 | Details |
Tedizolid Phosphate | C17H16FN6O6P | 856867-55-5 | Details |
Abiraterone acetate | C26H33NO2 | 154229-18-2 | Details |
Elagolix Sodium | C32H29F5N3NaO5 | 832720-36-2 | Details |
Bortezomib | C19H25BN4O4 | 179324-69-7 | Details |
Pemetrexed Disodium Heptahydrate | C20H24N5NaO7 | 357166-29-1 | Details |
brivaracetam | C11H20N2O2 | 357336-20-0 | Details |
(S)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate | C24H27ClFN4O6P | 618061-76-0 | Details |
Afatinib impurity;(R,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide | C24H25ClFN5O3 | 945553-91-3 | Details |
Afatinib impurity; | C22H23ClFN5O2 | 2085843-51-0 | Details |
4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide | C28H22F3N7O | 641571-15-5 | Details |
NILOTINIB IMPURITY | C29H24F3N7O | 2119583-24-1 | Details |
5-(piperazin-1-yl)pyridin-2-aMine | C9H14N4 | 1082876-26-3 | Details |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]- | C22H27N7O | 571190-22-2 | Details |
Palbociclib impurity D | C29H37N7O4 | 1651214-74-2 | Details |
Palbociclib impurity E | C22H26BrN7O | 851067-56-6 | Details |
Palbociclib impurity G | C24H29N7O | 2204863-06-7 | Details |
4-QuinazolinaMine | C18H14ClFN4O4 | 314771-88-5 | Details |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester | C18H16N4O2 | 917392-54-2 | Details |
3-Amino-4-methylbenzoic acid | C8H9NO2 | 2458-12-0 | Details |
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | C11H10F3N3 | 641571-11-1 | Details |
Alectinib hydrochloride | C30H35ClN4O2 | 1256589-74-8 | Details |
relugolix | C29H27F2N7O5S | 737789-87-6 | Details |
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine | C18H16ClFN4O2 | 314771-76-1 | Details |
AKOS BB-3093 | C10H13NO2 | 41191-92-8 | Details |
Product Total: Product Page: | ||||
1 |